EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway

Liyun Huo iD, Chong Wu, Xiaobo Li, Caina Ma, Jiamin Huang, Zishuo Chen, Weiling He, Tianyu Tao iD, Weijing Zhang

Advanced Science · 2026

DOI: 10.1002/advs.202522826 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Liyun Huo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Nucleotidyltransferases, Membrane Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, National Key Research And Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of immunotherapy in colorectal cancer (CRC) is frequently limited by an immunosuppressive tumor microenvironment. Here, we identify exonuclease/endonuclease/phosphatase domain‐containing protein 1 (EEPD1), a gatekeeper of homologous recombination (HR) repair, as a key driver of this immune exclusion. Downregulation of EEPD1 profoundly compromises HR in CRC cells, which curtails their proliferative and metastatic capacities in vitro and in vivo. Mechanistically, EEPD1 deficiency fuels genomic instability, leading to cytosolic DNA accumulation and activation of the cGAS‐STING‐type I interferon axis. This cascade promotes dendritic cell maturation, skews macrophages toward a proinflammatory M1 phenotype, and enhances tumor‐associated antigen presentation, culminating in robust CD8 + T cell activation and cytotoxicity. Our findings elucidate a direct mechanism by which targeting EEPD1 sensitizes CRC to anti‐PD1 immunotherapy. Our work establishes EEPD1 as a promising therapeutic target to overcome immune checkpoint blockade resistance in colorectal cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsNucleotidyltransferasesMembrane ProteinscGAS-STING Signaling PathwayAnimalsHumansCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseMiceSTING ProteinImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

EEPD1antitumor immunitycGAS‐STING pathwaycolorectal cancerimmunotherapy

Substanzen

Cyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseNucleotidyltransferasesSTING ProteincGAS protein, mouseMembrane ProteinscGAS protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • The Core Facilities for Medical Science at Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, Guangdong, China.
  • Department of Microbiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
  • Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Gastrointestinal Surgery, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.

ORCID-Profile: Liyun Huo, Tianyu Tao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province
  • National Key Research And Development Plan
  • Guangdong Science and Technology Planning Program
  • Fujian Provincial Health and Medical High-Level Talent Team
  • Key Technologies R&D Program of Guangdong Province
  • Guangdong Basic and Applied Basic Research Foundation
  • the Funding by Science and Technology Projects in Guangzhou

Zitieren

APA

Huo, L., Wu, C., Li, X., Ma, C., Huang, J., Chen, Z., He, W., Tao, T., & Zhang, W. (2026). EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway. Advanced Science. https://doi.org/10.1002/advs.202522826

Vancouver

Huo L, Wu C, Li X, Ma C, Huang J, Chen Z, et al. EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway. Advanced Science. 2026. doi:10.1002/advs.202522826

BibTeX
@article{Huo2026,
  author = {Huo, Liyun and Wu, Chong and Li, Xiaobo and Ma, Caina and Huang, Jiamin and Chen, Zishuo and He, Weiling and Tao, Tianyu and Zhang, Weijing},
  title = {EEPD1 Inhibition Unleashes Antitumor Immunity in Colorectal Cancer by Activating the cGAS‐STING Pathway},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202522826}
}
Kostenlos starten →